Clarisa Blattner: PAMA Reporting 2026—5 Strategic Priorities Clinical Laboratories Can’t Afford to Miss
Validating applicable laboratory status is an important first step in reporting
RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Already a member? Log in here
Recent MD Labs Ruling Has Implications for Test Requisitions and Commissions
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
Already a member? Log in here
OIG Report on Lab Testing Should Prompt Compliance Review
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
Already a member? Log in here
Overturning of Molecular Test Coverage Denials Varies Widely, According to UCSF Study
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
Already a member? Log in here